Neogen Corporation Form 425: Prospectus or communication for a business combination
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2022-08-18: Form 425; Description 425; Document ny20004078x24_425.htm.
- 2022-08-17: Form 425; Description 425; Document brhc10041003_425.htm.
- 2022-08-12: Form 425; Description 425; Document ny20003153x20_425.htm.
- 2022-08-05: Form 425; Description 425; Document ny20004078x22_425.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2022-08-18 | 425 | 425 | ny20004078x24_425.htm | |
| 2022-08-17 | 425 | 425 | brhc10041003_425.htm | |
| 2022-08-12 | 425 | 425 | ny20003153x20_425.htm | |
| 2022-08-05 | 425 | 425 | ny20004078x22_425.htm | |
| 2022-07-07 | 425 | 425 | ny20004504x5_425.htm | |
| 2022-04-21 | 425 | 425 | ny20003153x6_425.htm | |
| 2022-03-11 | 425 | FORM 425 | ny20003153x2_425.htm | |
| 2021-12-15 | 425 | 425 | d263426d425.htm | |
| 2021-12-15 | 425 | 425 | d271693d425.htm | |
| 2021-12-15 | 425 | 425 | d270738d425.htm | |
| 2021-12-14 | 425 | 425 | d271594d425.htm | |
| 2021-12-14 | 425 | 425 | d424807d425.htm | |
| 2021-12-14 | 425 | 425 | d273762d425.htm | |
| 2021-12-14 | 425 | 425 | d239646d425.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |